{"id":"W2612095536","doi":"10.1016/j.ejca.2017.04.007","title":"Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Vemurafenib; Medicine; Adverse effect; Internal medicine; Melanoma; Population; Metastatic melanoma; Clinical trial; Oncology; Dermatology; Surgery; Gastroenterology; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001876096,0.0008201677,0.002273239,0.0002743291,0.0004014923,0.0009216479,0.0005307576,0.0009214955,0.001662905],"category_scores_gemma":[0.001633149,0.0003974877,0.00186581,0.0004755886,0.0006843494,0.0009688354,0.0003631602,0.001318117,0.0005990589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006040228,"about_ca_system_score_gemma":0.0005274505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004058749,"about_ca_topic_score_gemma":0.0005999714,"domain_scores_codex":[0.9991247,0.0003989567,0.00006841944,0.0002007284,0.0001004584,0.0001067934],"domain_scores_gemma":[0.9984397,0.0004279152,0.000386749,0.000307892,0.0001230423,0.0003147051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8221194,0.007517752,0.09112382,0.0006773331,0.004705517,0.0005435397,0.0003437961,0.0022444,0.01888519,0.0001430214,0.001702607,0.04999376],"study_design_scores_gemma":[0.2614151,0.2086105,0.5078371,0.00009780314,0.005164476,0.001754621,0.0003498532,0.003136043,0.004858281,0.00058617,0.006012527,0.0001774919],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978258,0.0007497519,0.000228725,0.00004998717,0.00001981411,0.0001071437,0.0007451112,0.00001524443,0.0002583447],"genre_scores_gemma":[0.9958835,0.000317611,0.0002952912,0.0001522611,0.00005494584,0.0001883011,0.002418028,0.0000123283,0.0006776671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002273239,"threshold_uncertainty_score":0.009921908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03186342165667164,"score_gpt":0.3152514821229644,"score_spread":0.2833880604662927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}